{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:11:31Z","timestamp":1790626291220,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jat\/bkz041","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T07:24:32Z","timestamp":1556090672000},"source":"Crossref","is-referenced-by-count":9,"title":["Pregabalin and Its Involvement in Coronial Cases"],"prefix":"10.1093","author":[{"given":"Amanda","family":"Thompson","sequence":"first","affiliation":[{"name":"Forensic & Scientific Services, Health Support Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Morey","sequence":"additional","affiliation":[{"name":"Forensic & Scientific Services, Health Support Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Forensic & Scientific Services, Health Support Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"key":"2019051611313791600_bkz041C1","author":"Product Information: Lyrica (pregabalin), Pfizer Australia","year":"2013"},{"key":"2019051611313791600_bkz041C2","author":"Highlights of Prescribing Information Lyrica, FDA","year":"2012"},{"key":"2019051611313791600_bkz041C3","author":"Lyrica (pregabalin), European Medicines Agency","year":"2014"},{"key":"2019051611313791600_bkz041C4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00228-012-1464-6","article-title":"Pregabalin abuse and dependence in Germany: results from a database query","volume":"69","author":"Gahr","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"2019051611313791600_bkz041C5","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"2019051611313791600_bkz041C6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.forsciint.2014.06.030","article-title":"Pregabalin serum levels in apprehended drivers","volume":"243","author":"Kriikku","year":"2014","journal-title":"Forensic Science International"},{"key":"2019051611313791600_bkz041C7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/add.13843","article-title":"Risk to heroin users of polydrug use of pregabalin or gabapentin","volume":"112","author":"Lyndon","year":"2017","journal-title":"Addiction (Abingdon, England)"},{"key":"2019051611313791600_bkz041C8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","article-title":"Profiles of pregabalin and gabapentin abuse by postmortem toxicology","volume":"241","author":"Hakkinen","year":"2014","journal-title":"Forensic Science International"},{"key":"2019051611313791600_bkz041C9","first-page":"339","article-title":"Abuse of pregabalin - results of the postmortem toxicology from 2010 to 2012","volume":"80","author":"Lottner-Nau","year":"2013","journal-title":"Toxichem Krimtech"},{"key":"2019051611313791600_bkz041C10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1556-4029.13263","article-title":"Determining the toxicological significance of pregabalin in fatalities","volume":"62","author":"Elliott","year":"2017","journal-title":"Journal of Forensic Sciences"},{"key":"2019051611313791600_bkz041C11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.forsciint.2016.05.033","article-title":"Pregabalin concentrations in post-mortem blood-A two year study","volume":"266","author":"Eastwood","year":"2016","journal-title":"Forensic Science International"},{"key":"2019051611313791600_bkz041C12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jat\/bkx019","article-title":"Validated method for the screening and quantification of baclofen, gabapentin and pregabalin in human post-mortem whole blood using protein precipitation and liquid chromatography-tandem mass spectrometry","volume":"41","author":"Nahar","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"2019051611313791600_bkz041C13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/jat\/bku004","article-title":"Quantification of pregabalin using hydrophilic interaction HPLC-high-resolution MS in postmortem human samples: eighteen case reports","volume":"38","author":"Priez-Barallon","year":"2014","journal-title":"Journal of Analytical Toxicology"},{"key":"2019051611313791600_bkz041C14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jat\/bku070","article-title":"Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases","volume":"38","author":"Deeb","year":"2014","journal-title":"Journal of Analytical Toxicology"},{"key":"2019051611313791600_bkz041C15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jchromb.2014.05.030","article-title":"Simultaneous determination of gabapentin, pregabalin, vigabatrin, and topiramate in plasma by HPLC with fluorescence detection","volume":"962","author":"Martinc","year":"2014","journal-title":"Journal of Chromatography B"},{"key":"2019051611313791600_bkz041C16","author":"Australian Government","year":"2017"},{"key":"2019051611313791600_bkz041C17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40263-015-0303-6","article-title":"Abuse potential of pregabalin: a systematic review","volume":"30","author":"Schjerning","year":"2016","journal-title":"CNS Drugs"},{"key":"2019051611313791600_bkz041C18","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"2019051611313791600_bkz041C19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"2019051611313791600_bkz041C20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/FTD.0b013e31815d0cd5","article-title":"Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age and comedication","volume":"29","author":"May","year":"2007","journal-title":"Therapeutic Drug Monitoring"},{"key":"2019051611313791600_bkz041C21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.ftd.0000158874.54100.1a","article-title":"Analysis of pregabalin at therapeutic concentrations in human plasma\/serum by reversed-phase HPLC","volume":"27","author":"Berry","year":"2005","journal-title":"Therapeutic Drug Monitoring"},{"key":"2019051611313791600_bkz041C22","author":"Australian Institute of Health and Welfare","year":"2017"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkz041\/28654974\/bkz041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:36:14Z","timestamp":1558006574000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/advance-article\/doi\/10.1093\/jat\/bkz041\/5490235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1093\/jat\/bkz041","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]},"article-number":"bkz041"}}